| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.38 | 0.2 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.35 | 0.05 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.25 | 0.6 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.24 | 0.06 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.21 | 0.2 |